دورية أكاديمية
أعرض في EDS

Isolation and Characterization of the First Zobellviridae Family Bacteriophage Infecting Klebsiella pneumoniae .

التفاصيل البيبلوغرافية
العنوان: Isolation and Characterization of the First Zobellviridae Family Bacteriophage Infecting Klebsiella pneumoniae .
المؤلفون: Gorodnichev RB; Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia., Kornienko MA; Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia., Malakhova MV; Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia., Bespiatykh DA; Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia., Manuvera VA; Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia., Selezneva OV; Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia., Veselovsky VA; Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia., Bagrov DV; Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia.; Department of Bioengineering, Faculty of Biology, Lomonosov Moscow State University, 119234 Moscow, Russia., Zaychikova MV; Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia., Osnach VA; Saint Petersburg Pasteur Institute, Federal Service on Consumer Rights Protection and Human Well-Being Surveillance, 197101 St. Petersburg, Russia., Shabalina AV; Saint Petersburg Pasteur Institute, Federal Service on Consumer Rights Protection and Human Well-Being Surveillance, 197101 St. Petersburg, Russia., Goloshchapov OV; R.M. Gorbacheva Memorial Institute of Oncology, Hematology and Transplantation, Pavlov First Saint Petersburg State Medical University, 197022 St. Petersburg, Russia., Bespyatykh JA; Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia., Dolgova AS; Saint Petersburg Pasteur Institute, Federal Service on Consumer Rights Protection and Human Well-Being Surveillance, 197101 St. Petersburg, Russia., Shitikov EA; Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia.
المصدر: International journal of molecular sciences [Int J Mol Sci] 2023 Feb 17; Vol. 24 (4). Date of Electronic Publication: 2023 Feb 17.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI, [2000-
مواضيع طبية MeSH: Bacteriophages*/genetics , Podoviridae*/genetics, Klebsiella pneumoniae/genetics ; Phylogeny ; Genome, Viral ; Recombinant Proteins/genetics
مستخلص: In order to address the upcoming crisis in the treatment of Klebsiella pneumoniae infections, caused by an increasing proportion of resistant isolates, new approaches to antimicrobial therapy must be developed. One approach would be to use (bacterio)phages and/or phage derivatives for therapy. In this study, we present a description of the first K. pneumoniae phage from the Zobellviridae family. The vB_KpnP_Klyazma podovirus, which forms translucent halos around the plaques, was isolated from river water. The phage genome is composed of 82 open reading frames, which are divided into two clusters located on opposite strands. Phylogenetic analysis revealed that the phage belongs to the Zobellviridae family, although its identity with the closest member of this family was not higher than 5%. The bacteriophage demonstrated lytic activity against all ( n = 11) K. pneumoniae strains with the KL20 capsule type, but only the host strain was lysed effectively. The receptor-binding protein of the phage was identified as a polysaccharide depolymerase with a pectate lyase domain. The recombinant depolymerase protein showed concentration-dependent activity against all strains with the KL20 capsule type. The ability of a recombinant depolymerase to cleave bacterial capsular polysaccharides regardless of a phage's ability to successfully infect a particular strain holds promise for the possibility of using depolymerases in antimicrobial therapy, even though they only make bacteria sensitive to environmental factors, rather than killing them directly.
References: Methods Mol Biol. 2009;501:15-21. (PMID: 19066806)
J Virol. 2012 Aug;86(15):7907-17. (PMID: 22593163)
PLoS Genet. 2019 Apr 15;15(4):e1008114. (PMID: 30986243)
J Antimicrob Chemother. 2020 Feb 1;75(2):309-317. (PMID: 31702790)
Bioinformatics. 2017 Aug 01;33(15):2379-2380. (PMID: 28379287)
Sci Rep. 2017 Aug 15;7(1):8292. (PMID: 28811656)
Nucleic Acids Res. 2009 Jan;37(Database issue):D443-7. (PMID: 18832362)
Lancet Infect Dis. 2018 Jan;18(1):37-46. (PMID: 28864030)
J Clin Microbiol. 2018 Aug 27;56(9):. (PMID: 29925642)
PLoS One. 2015 Mar 11;10(3):e0118557. (PMID: 25761060)
Viruses. 2016 Dec 01;8(12):. (PMID: 27916936)
New Microbiol. 2022 Jun;45(2):124-129. (PMID: 35699561)
BMC Infect Dis. 2014 Aug 23;14:456. (PMID: 25149315)
Appl Microbiol Biotechnol. 2016 Mar;100(5):2141-51. (PMID: 26767986)
Curr Opin Virol. 2022 Feb;52:24-29. (PMID: 34801778)
Methods Mol Biol. 2019;1962:1-14. (PMID: 31020551)
Antimicrob Agents Chemother. 2016 Sep 23;60(10):6115-20. (PMID: 27480857)
Pharmaceuticals (Basel). 2021 Oct 03;14(10):. (PMID: 34681243)
Open Forum Infect Dis. 2020 Aug 27;7(9):ofaa389. (PMID: 33005701)
Front Microbiol. 2020 Feb 14;11:218. (PMID: 32117192)
Antibiotics (Basel). 2021 Dec 08;10(12):. (PMID: 34943720)
J Clin Microbiol. 2013 Dec;51(12):4073-8. (PMID: 24088853)
Acta Biochim Pol. 2015;62(4):867-74. (PMID: 26637376)
Methods Mol Biol. 2009;501:141-9. (PMID: 19066818)
Nucleic Acids Res. 2001 Jun 15;29(12):2607-18. (PMID: 11410670)
Virology. 2016 Feb;489:116-27. (PMID: 26748333)
Lancet. 2022 Feb 12;399(10325):629-655. (PMID: 35065702)
Virus Res. 2022 Dec;322:198951. (PMID: 36191686)
J Glob Antimicrob Resist. 2017 Jun;9:17-18. (PMID: 28336324)
Bioinformatics. 2021 Jan 18;:. (PMID: 33459763)
Curr Protoc Bioinformatics. 2020 Mar;69(1):e96. (PMID: 32162851)
Methods Mol Biol. 2009;501:81-5. (PMID: 19066813)
Adv Exp Med Biol. 2019;1148:233-253. (PMID: 31482502)
Genome Announc. 2015 Jul 16;3(4):. (PMID: 26184927)
Nat Microbiol. 2020 Mar;5(3):465-472. (PMID: 32066959)
Arch Virol. 2018 Sep;163(9):2377-2383. (PMID: 29749589)
Methods Mol Biol. 2009;501:151-5. (PMID: 19066819)
J Clin Microbiol. 2005 Aug;43(8):4178-82. (PMID: 16081970)
Clin Microbiol Rev. 2019 May 15;32(3):. (PMID: 31092506)
Infect Immun. 1989 Feb;57(2):546-52. (PMID: 2643575)
Front Microbiol. 2021 Aug 09;12:669618. (PMID: 34434173)
Mol Biol Evol. 2020 May 1;37(5):1530-1534. (PMID: 32011700)
J Comput Biol. 2012 May;19(5):455-77. (PMID: 22506599)
J Exp Med. 2004 Mar 1;199(5):697-705. (PMID: 14993253)
Front Immunol. 2022 Mar 21;13:843183. (PMID: 35386691)
Infect Genet Evol. 2016 Apr;39:99-105. (PMID: 26723920)
Nucleic Acids Res. 2004 Jan 02;32(1):11-6. (PMID: 14704338)
Mol Biol Evol. 2018 Feb 1;35(2):518-522. (PMID: 29077904)
Virology. 2003 Jun 5;310(2):359-71. (PMID: 12781722)
Int J Infect Dis. 2020 Sep;98:281-286. (PMID: 32619765)
Front Microbiol. 2018 Oct 25;9:2561. (PMID: 30410478)
Appl Microbiol Biotechnol. 2017 Apr;101(8):3103-3119. (PMID: 28337580)
J Virol. 2013 Aug;87(16):9189-98. (PMID: 23760254)
Antibiotics (Basel). 2021 Dec 06;10(12):. (PMID: 34943709)
Sci Rep. 2020 Nov 23;10(1):20338. (PMID: 33230270)
Nat Methods. 2017 Jun;14(6):587-589. (PMID: 28481363)
Microbiol Mol Biol Rev. 2016 Jun 15;80(3):629-61. (PMID: 27307579)
Nucleic Acids Res. 2019 Jan 8;47(D1):D687-D692. (PMID: 30395255)
Nat Med. 2019 May;25(5):730-733. (PMID: 31068712)
J Mol Biol. 2008 Mar 28;377(3):774-89. (PMID: 18294652)
Arch Virol. 2016 Feb;161(2):499-501. (PMID: 26577901)
Pharmaceutics. 2022 Sep 10;14(9):. (PMID: 36145665)
Bacteriophage. 2011 Jan;1(1):31-45. (PMID: 21687533)
Front Microbiol. 2020 Jun 18;11:1199. (PMID: 32625176)
Virus Res. 2018 Jan 2;243:10-18. (PMID: 28988127)
Med Res Rev. 2020 Jan;40(1):459-463. (PMID: 31062882)
Mol Biol Evol. 2021 Aug 23;38(9):4039-4042. (PMID: 34097064)
Arch Intern Med. 1986 Oct;146(10):1913-6. (PMID: 3532983)
Methods Mol Biol. 2009;501:113-26. (PMID: 19066816)
معلومات مُعتمدة: Code: Bacteriophage-2 State Assignment on the Development of a complex therapy scheme for drug-resistant pathogens of infectious diseases using bacteriophages or their derivatives in combination with antibacterial drugs
فهرسة مساهمة: Keywords: Klebsiella pneumoniae; Zobellviridae; bacteriophage; capsular type; capsule depolymerase; multidrug resistance
المشرفين على المادة: 0 (Recombinant Proteins)
تواريخ الأحداث: Date Created: 20230225 Date Completed: 20230228 Latest Revision: 20230228
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC9960094
DOI: 10.3390/ijms24044038
PMID: 36835449
قاعدة البيانات: MEDLINE
الوصف
تدمد:1422-0067
DOI:10.3390/ijms24044038